{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:45:58Z","timestamp":1791902758161,"version":"4.3.4"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Amyotrophic lateral sclerosis (ALS) is a rare, devastating neurodegenerative disease that affects upper and lower motor neurons. To date, no effective treatment or reliable biomarker for ALS has been developed. In recent years, many factors have been proposed as possible biomarkers of ALS; however, no consensus has been reached. Therefore, a reliable biomarker is urgently needed. Eosinophils may play a crucial role in healthy humans and diseases, and serve as a biomarker for many chronic diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Routine blood test results were collected from 66 healthy controls and 59 patients with ALS. The percentages and total numbers of each cell population were analyzed, and the correlation between these indicators and patient ALS functional rating scale\u2013revised (ALSFRS-R) score or disease progression rate (\u0394FS score) was analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared to healthy controls, the number of blood leukocytes, neutrophils, monocytes, and basophils was significantly decreased in patients with ALS (<jats:italic>p<\/jats:italic>\u2009=\u20090.002, <jats:italic>p<\/jats:italic>\u2009=\u20090.001, <jats:italic>p<\/jats:italic>\u2009=\u20090.049, and <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.0001, respectively). There was an increase in the number of eosinophils (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.0001), but no difference in the number of lymphocytes between patients with ALS and healthy controls was found (<jats:italic>p<\/jats:italic>\u2009=\u20090.563). Compared to healthy controls, the percentage of neutrophils was decreased and the percentage of lymphocytes and eosinophils was increased in patients with ALS (<jats:italic>p<\/jats:italic>\u2009=\u20090.01, <jats:italic>p<\/jats:italic>\u2009=\u20090.012, and <jats:italic>p<\/jats:italic>\u2009=\u20090.001, respectively). There was no difference between patients with ALS and healthy controls in the percentage of monocytes and basophils (<jats:italic>p<\/jats:italic>\u2009=\u20090.622 and <jats:italic>p<\/jats:italic>\u2009=\u20090.09, respectively). However, only the percentage and number of eosinophils had a correlation with the \u0394FS score. Further multivariate analysis revealed a significant correlation between the disease duration, eosinophil count and percentage, and the disease progression rate (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.0001, <jats:italic>p<\/jats:italic>\u2009=\u20090.048, and <jats:italic>p<\/jats:italic>\u2009=\u20090.023, respectively). The neutrophil-to-eosinophil ratio (NER), lymphocyte-to-eosinophil ratio (LER), and monocyte-to-eosinophil ratio (MER) were significantly lower in patients with ALS than in healthy controls. However, only the LER was significantly correlated with the \u0394FS score.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These observations implicate neutrophils, lymphocytes, and eosinophils as important factors, and increasing eosinophil counts were negatively correlated with the \u0394FS score in patients with ALS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2023.1289467","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T04:29:06Z","timestamp":1703132946000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Eosinophils at diagnosis are elevated in amyotrophic lateral sclerosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Jing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng Ping","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3109\/17482960903009054","article-title":"The natural history of ALS is changing: improved survival","volume":"10","author":"Qureshi","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole Study Group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1001\/jamaneurol.2021.4893","article-title":"Safety and effectiveness of long-term intravenous administration of edaravone for treatment of patients with amyotrophic lateral sclerosis","volume":"79","author":"Witzel","year":"2022","journal-title":"JAMA Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"890958","DOI":"10.3389\/fnagi.2022.890958","article-title":"Neuroimmune crosstalk between the peripheral and the central immune system in amyotrophic lateral sclerosis","volume":"14","author":"Yu","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fneur.2020.00279","article-title":"The peripheral immune system and amyotrophic lateral sclerosis","volume":"11","author":"McCombe","year":"2020","journal-title":"Front Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/mus.26289","article-title":"Inflammation, immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology","volume":"59","author":"Lyon","year":"2019","journal-title":"Muscle Nerve"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1474-4422(18)30394-6","article-title":"Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies","volume":"18","author":"Beers","year":"2019","journal-title":"Lancet Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/jamaneurol.2017.2255","article-title":"Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression","volume":"74","author":"Murdock","year":"2017","journal-title":"JAMA Neurol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e242","DOI":"10.1212\/NXI.0000000000000242","article-title":"Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis","volume":"3","author":"Murdock","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41598-019-57366-y","article-title":"High neutrophil-to-lymphocyte ratio predicts short survival duration in amyotrophic lateral sclerosis","volume":"10","author":"Choi","year":"2020","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III)","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"J Neurol Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12974-022-02421-1","article-title":"ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression","volume":"19","author":"Quek","year":"2022","journal-title":"J Neuroinflammation"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1111\/ene.14409","article-title":"Blood biomarkers and prognosis of amyotrophic lateral sclerosis","volume":"27","author":"Sun","year":"2020","journal-title":"Eur J Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/WCO.0000000000000744","article-title":"Neurochemical biomarkers in amyotrophic lateral sclerosis","volume":"32","author":"Verde","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00415-012-6440-7","article-title":"Uric acid levels predict survival in men with amyotrophic lateral sclerosis","volume":"259","author":"Paganoni","year":"2012","journal-title":"J Neurol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/jamaneurol.2016.6179","article-title":"Serum C-reactive protein as a prognostic biomarker in amyotrophic lateral sclerosis","volume":"74","author":"Lunetta","year":"2017","journal-title":"JAMA Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1001\/jamaneurol.2014.1129","article-title":"Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study","volume":"71","author":"Chio","year":"2014","journal-title":"JAMA Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/ajcn\/74.3.328","article-title":"Factors correlated with hypermetabolism in patients with ALS","volume":"74","author":"Desport","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e74065","DOI":"10.7554\/eLife.74065","article-title":"Correlation between leukocyte phenotypes and prognosis of amyotrophic lateral sclerosis","volume":"11","author":"Cui","year":"2022","journal-title":"eLife"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.alit.2020.09.002","article-title":"Eosinophils: cells known for over 140 years with broad and new functions","volume":"70","author":"Aoki","year":"2021","journal-title":"Allergol Int"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.mayocp.2021.04.025","article-title":"Eosinophils in health and disease: a state-of-the-art review","volume":"96","author":"Wechsler","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-2222.2008.02958.x","article-title":"Eosinophils: biological properties and role in health and disease","volume":"38","author":"Hogan","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s42255-020-0228-3","article-title":"Eosinophils regulate adipose tissue inflammation and sustain physical and immunological fitness in old age","volume":"2","author":"Brigger","year":"2020","journal-title":"Nat Metab"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"686983","DOI":"10.3389\/fneur.2021.686983","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio in stroke: a systematic review and meta-analysis","volume":"12","author":"Li","year":"2021","journal-title":"Front Neurol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/biomedicines10010075","article-title":"Neutrophil to lymphocyte ratio (NLR)-a useful tool for the prognosis of Sepsis in the ICU","volume":"10","author":"Dragoescu","year":"2021","journal-title":"Biomedicines"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.12669\/pjms.37.5.4194","article-title":"Neutrophil to lymphocyte ratio (NLR) in COVID-19: a cheap prognostic marker in a resource constraint setting","volume":"37","author":"Toori","year":"2021","journal-title":"Pak J Med Sci"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s12094-016-1593-y","article-title":"Neutrophil to lymphocyte ratio associated with prognosis of lung cancer","volume":"19","author":"Bar-Ad","year":"2017","journal-title":"Clin Transl Oncol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jacig.2022.09.001","article-title":"Rethinking blood eosinophil counts: epidemiology, associated chronic diseases, and increased risks of cardiovascular disease","volume":"1","author":"Pongdee","year":"2022","journal-title":"J Allergy Clin Immunol Glob"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"44571","DOI":"10.1038\/srep44571","article-title":"Eosinophils are key regulators of perivascular adipose tissue and vascular functionality","volume":"7","author":"Withers","year":"2017","journal-title":"Sci Rep"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1038\/s41467-020-16758-9","article-title":"Eosinophil function in adipose tissue is regulated by Kruppel-like factor 3 (KLF3)","volume":"11","author":"Knights","year":"2020","journal-title":"Nat Commun"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1126\/science.1201475","article-title":"Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis","volume":"332","author":"Wu","year":"2011","journal-title":"Science"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.immuni.2022.05.014","article-title":"Small intestinal resident eosinophils maintain gut homeostasis following microbial colonization","volume":"55","author":"Ignacio","year":"2022","journal-title":"Immunity"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12916-020-01885-3","article-title":"The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS)","volume":"19","author":"Boddy","year":"2021","journal-title":"BMC Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-019-1443-5","article-title":"Potential roles of gut microbiome and metabolites in modulating ALS in mice","volume":"572","author":"Blacher","year":"2019","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3390\/biomedicines10020354","article-title":"Neutrophils-to-lymphocyte ratio is associated with progression and overall survival in amyotrophic lateral sclerosis","volume":"10","author":"Leone","year":"2022","journal-title":"Biomedicines"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/21678421.2020.1813310","article-title":"Interleukin 6 (IL6) level is a biomarker for functional disease progression within IL6R358Ala variant groups in amyotrophic lateral sclerosis patients","volume":"22","author":"Wosiski-Kuhn","year":"2021","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1172\/JCI62636","article-title":"Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS","volume":"122","author":"Butovsky","year":"2012","journal-title":"J Clin Invest"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1289467\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T04:29:09Z","timestamp":1703132949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1289467\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":39,"alternative-id":["10.3389\/fneur.2023.1289467"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1289467","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,21]]},"article-number":"1289467"}}